Saccharomyces boulardii
Saccharomyces boulardii is a dietary supplement with 17 clinical trials. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
10 of 12 finished
16.7%
2 ended early
0
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
Clinical Trials (17)
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea
Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota
Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota
Impact of Probiotics on the Intestinal Microbiota
Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea
Impact of Probiotics in Modulation of Intestinal Microbiota
Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant
Saccharomyces Boulardii in Irritable Bowel Syndrome
A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA
Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants
Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome
Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial
All 17 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 17